Edoxaban Management in Diagnostic and Therapeutic Procedures
Phase of Trial: Phase IV
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Edoxaban (Primary)
- Indications Atrial fibrillation; Venous thromboembolism
- Focus Adverse reactions
- Acronyms EMIT-AF/VTE
- Sponsors Daiichi Sankyo Inc
- 08 Dec 2016 According to a Daiichi Sankyo Company media release, first patient has been enrolled in this trial.
- 08 Dec 2016 Status changed from not yet recruiting to recruiting, as reported in a Daiichi Sankyo Company media release.
- 04 Nov 2016 New trial record